JP2010500375A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500375A5
JP2010500375A5 JP2009523983A JP2009523983A JP2010500375A5 JP 2010500375 A5 JP2010500375 A5 JP 2010500375A5 JP 2009523983 A JP2009523983 A JP 2009523983A JP 2009523983 A JP2009523983 A JP 2009523983A JP 2010500375 A5 JP2010500375 A5 JP 2010500375A5
Authority
JP
Japan
Prior art keywords
stage
particle
stage particle
composition
nanoporous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009523983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500375A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/075516 external-priority patent/WO2008021908A2/en
Publication of JP2010500375A publication Critical patent/JP2010500375A/ja
Publication of JP2010500375A5 publication Critical patent/JP2010500375A5/ja
Pending legal-status Critical Current

Links

JP2009523983A 2006-08-08 2007-08-08 活性剤の多段階送達 Pending JP2010500375A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82175006P 2006-08-08 2006-08-08
US91434807P 2007-04-27 2007-04-27
PCT/US2007/075516 WO2008021908A2 (en) 2006-08-08 2007-08-08 Multistage delivery of active agents

Publications (2)

Publication Number Publication Date
JP2010500375A JP2010500375A (ja) 2010-01-07
JP2010500375A5 true JP2010500375A5 (enExample) 2010-09-24

Family

ID=39082940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009523983A Pending JP2010500375A (ja) 2006-08-08 2007-08-08 活性剤の多段階送達

Country Status (8)

Country Link
US (4) US20080311182A1 (enExample)
EP (1) EP2056794A4 (enExample)
JP (1) JP2010500375A (enExample)
CN (1) CN101652126B (enExample)
AU (1) AU2007286203B2 (enExample)
CA (1) CA2664919A1 (enExample)
MX (1) MX2009001461A (enExample)
WO (1) WO2008021908A2 (enExample)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2567741A1 (en) 2004-05-25 2006-03-30 Chimeracore, Inc. Self-assembling nanoparticle drug delivery system
US7854944B2 (en) * 2004-12-17 2010-12-21 Advanced Cardiovascular Systems, Inc. Tissue regeneration
AU2007348315A1 (en) 2006-04-07 2008-09-12 Chimeros, Inc. Compositions and methods for treating B- cell malignancies
US8563022B2 (en) * 2006-10-11 2013-10-22 Board Of Regents Of The University Of Texas System Particles for cell targeting
WO2008106350A1 (en) * 2007-02-26 2008-09-04 Board Of Regents Of The University Of Texas System Endocytotic particles
US8920625B2 (en) * 2007-04-27 2014-12-30 Board Of Regents Of The University Of Texas System Electrochemical method of making porous particles using a constant current density
AU2009238607B2 (en) * 2008-04-25 2015-08-06 Northwestern University Nanostructures suitable for sequestering cholesterol
US8173115B2 (en) 2008-07-29 2012-05-08 The Board Of Regents Of The University Of Texas System Particle compositions with a pre-selected cell internalization mode
CA2732252A1 (en) * 2008-07-29 2010-02-04 Paolo Decuzzi Particle compositions with a pre-selected cell internalization mode
WO2010025322A2 (en) * 2008-08-28 2010-03-04 The Florida International University Board Of Trustees Magnetic nanodelivery of therapeutic agents across the blood brain barrier
CA2747318A1 (en) * 2008-12-23 2010-07-01 Mauro Ferrari Inflammation targeting particles
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
EP2376064A4 (en) * 2009-01-15 2013-08-21 Univ Texas POROUS STRUCTURES WITH MODIFIED ORGANIC BIOLOGICAL DERIVATION
JP5960434B2 (ja) * 2009-02-18 2016-08-02 アラダイム コーポレーション 肺送達のためのｐＨ調節された製剤
US8808733B2 (en) 2009-03-31 2014-08-19 The Board Of Trustees Of The University Of Arkansas Method of controlled drug release from a liposome carrier
WO2010120874A2 (en) 2009-04-14 2010-10-21 Chimeros, Inc. Chimeric therapeutics, compositions, and methods for using same
JP2012526130A (ja) * 2009-05-05 2012-10-25 アルテルムネ テクフノロジエス，エルエルシー 化学的にプログラム可能な免疫
FR2948024B1 (fr) * 2009-07-17 2020-01-10 Centre National De La Recherche Scientifique - Cnrs - Emulsion activable par ultrasons et son procede de fabrication.
WO2011038111A1 (en) * 2009-09-23 2011-03-31 Crystalplex Corporation Passivated nanoparticles
ES2367959B1 (es) * 2009-12-22 2013-01-24 Centro De Investigación Biomédica En Red En Bioingeniería, Biomateriales Y Nanomedicina Particulas magnético-luminiscentes para aplicaciones biomédicas.
AU2011207563B2 (en) 2010-01-19 2016-03-10 Northwestern University Synthetic nanostructures including nucleic acids and/or other entities
EP2540311A4 (en) * 2010-02-26 2016-07-06 Univ Nagasaki COMPOSITE BODY FOR THE ADMINISTRATION OF ANTIGENES OR MEDICINES
CN103081107B (zh) 2010-03-09 2017-02-08 得克萨斯州大学系统董事会 多孔和非多孔纳米结构
EP2547329A4 (en) * 2010-03-17 2014-06-25 Univ Texas THEROSTATIC DELIVERY SYSTEMS WITH MODIFIED SURFACES
EP2590605A1 (en) 2010-07-09 2013-05-15 Board of Regents of the University of Texas System Biodegradable scaffolds
CA2808019C (en) * 2010-08-16 2019-12-03 Australian Nuclear Science & Technology Organisation Particulate substances comprising ceramic particles for delivery of biomolecules
US20130224282A1 (en) * 2010-09-21 2013-08-29 Massachusetts Institute Of Technology Multistage Nanoparticles
RU2475233C2 (ru) * 2010-12-01 2013-02-20 Учреждение Российской академии наук Институт кристаллографии им. А.В. Шубникова РАН Фармакологическая композиция, предназначенная для интраназального введения с целью доставки в мозг фармакологически активного компонента, и способ ее получения
US9089498B2 (en) * 2011-04-14 2015-07-28 The Regents Of The University Of California Multifunctional nanoparticle designs and applications
US9541480B2 (en) 2011-06-29 2017-01-10 Academia Sinica Capture, purification, and release of biological substances using a surface coating
US9101547B2 (en) 2011-08-04 2015-08-11 Nano And Advanced Materials Institute Limited Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery
US8859004B2 (en) 2011-08-04 2014-10-14 Nano And Advanced Materials Institute Limited pH-sensitive nanoparticles for oral insulin delivery
JP2014527072A (ja) 2011-09-09 2014-10-09 バイオメド リアルティー， エル．ピー． ウイルスタンパク質の集合を制御するための方法および組成物
WO2013095736A2 (en) * 2011-09-27 2013-06-27 The Methodist Hospital Research Institute Gold-in-silicon nanoassembly for thermal therapy and methods of use
WO2013070872A1 (en) 2011-11-08 2013-05-16 The Board Of Trustees Of The University Of Arkansas Methods and compositions for x-ray induced release from ph sensitive liposomes
US8926994B2 (en) * 2011-12-07 2015-01-06 The Methodist Hospital Research Institute Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity
US20130304050A1 (en) * 2012-05-10 2013-11-14 Wake Forest University Health Sciences Methods of treating cancerous tissue
US10842749B2 (en) * 2012-06-12 2020-11-24 The Methodist Hospital Research Institute Compositions and methods of treating therapy resistant cancer and uses thereof
US8883216B2 (en) * 2012-08-27 2014-11-11 Red Lion Chem Tech, Llc Methods and ceramic nanoparticle compositions for heavy metal removal and for oral delivery of desirable agents
US20140120157A1 (en) * 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
CA2912975A1 (en) * 2012-10-16 2014-04-24 William Marsh Rice University An improved nanovector based drug delivery system for overcoming drug resistance
WO2014110449A1 (en) * 2013-01-10 2014-07-17 Amrita Vishwa Vidyapeetham Stannous doped micro and nano particles for augmented radiofrequency ablation
JP2015007209A (ja) * 2013-05-31 2015-01-15 株式会社リコー コアシェル型粒子、及びその製造方法
WO2015013673A1 (en) 2013-07-25 2015-01-29 Aurasense Therapeutics, Llc Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
WO2015023797A1 (en) 2013-08-13 2015-02-19 Northwestern University Lipophilic nanoparticles for drug delivery
WO2015066212A2 (en) * 2013-10-31 2015-05-07 University Of Hawaii Calpain inhibitors for treatment of inflammatory bowel disease and colorectal cancer
US10182988B2 (en) 2013-12-03 2019-01-22 Northwestern University Liposomal particles, methods of making same and uses thereof
EP3126814B1 (en) 2014-04-01 2019-06-12 Academia Sinica Methods and systems for cancer diagnosis and prognosis
WO2015176025A1 (en) 2014-05-15 2015-11-19 The Methodist Hospital Discoidal polymeric nanoconstructs and methods of use in cancer theranostics
US10995267B2 (en) 2014-05-29 2021-05-04 Crystalplex Corporation Dispersion system for quantum dots having organic coatings comprising free polar and non-polar groups
AU2015269412B2 (en) 2014-06-04 2020-03-12 Exicure Operating Company Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
CN115607688A (zh) 2014-07-22 2023-01-17 雷莫内克斯生物制药有限公司 用于递送生物活性物质或蛋白质的组合物及其用途
EP3183007B1 (en) 2014-08-19 2020-06-17 Northwestern University Protein/oligonucleotide core-shell nanoparticle therapeutics
EP2998026B1 (en) 2014-08-26 2024-01-17 Academia Sinica Collector architecture layout design
KR102510540B1 (ko) 2014-10-03 2023-03-16 나노틱스 엘엘씨 가용성 생물분자의 생물학적 활성을 억제하기 위한 조성물 및 방법
JP6741673B2 (ja) 2014-10-06 2020-08-19 イグジキュア, インコーポレーテッドExicure, Inc. 抗ｔｎｆ化合物
JP2017537619A (ja) 2014-11-21 2017-12-21 ノースウェスタン ユニバーシティ 球状核酸ナノ粒子複合体の配列特異的細胞内取込
US10736845B2 (en) 2015-03-03 2020-08-11 Cureport Inc. Dual loaded liposomal pharmaceutical formulations
US9895313B2 (en) 2015-03-03 2018-02-20 Cureport, Inc. Combination liposomal pharmaceutical formulations
US10078092B2 (en) 2015-03-18 2018-09-18 Northwestern University Assays for measuring binding kinetics and binding capacity of acceptors for lipophilic or amphiphilic molecules
CN114533898B (zh) * 2015-07-09 2025-07-01 加利福尼亚大学董事会 融合脂质体包被的多孔硅纳米颗粒
US20170056327A1 (en) * 2015-08-25 2017-03-02 The Methodist Hospital Micro/nano composite drug delivery formulations and uses thereof
ITUB20159209A1 (it) * 2015-12-21 2017-06-21 Fidia Farm Spa Nanosistemi per il trasporto controllato di molecole attive a fini diagnostici, prognostici e terapeutici
WO2017156191A1 (en) * 2016-03-08 2017-09-14 Los Gatos Pharmaceuticals, Inc. Composite nanoparticles and uses thereof
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
WO2017193087A1 (en) 2016-05-06 2017-11-09 Exicure, Inc. Liposomal spherical nucleic acid (sna) constructs prsenting antisense oligonucleotides(aso) for specific knockdown of interleukin 17 receptor mrna
US20190177615A1 (en) 2016-05-19 2019-06-13 Crystalplex Corporation Cadmium-free quantum dots, tunable quantum dots, quantum dot containing polymer, articles, films, and 3d structure containing them and methods of making and using them
WO2018039629A2 (en) 2016-08-25 2018-03-01 Northwestern University Micellar spherical nucleic acids from thermoresponsive, traceless templates
IL299915A (en) 2017-01-04 2023-03-01 Nanotics Llc Methods for assembling cleaning particles
CN110475546A (zh) 2017-02-06 2019-11-19 雷莫内克斯生物制药有限公司 生理活性物质载体
WO2018201090A1 (en) 2017-04-28 2018-11-01 Exicure, Inc. Synthesis of spherical nucleic acids using lipophilic moieties
WO2019032241A1 (en) 2017-07-13 2019-02-14 Northwestern University GENERAL AND DIRECT METHOD FOR PREPARING NANOPARTICLES WITH ORGANOMETALLIC STRUCTURE FUNCTIONALIZED BY OLIGONUCLEOTIDES
JP6865491B2 (ja) * 2017-07-25 2021-04-28 レモネックス インコーポレイテッドＬｅｍｏｎｅｘ Ｉｎｃ． 血管内生理活性物質送達用組成物
KR102152348B1 (ko) 2017-09-05 2020-09-08 주식회사 레모넥스 세포 운명 조절용 조성물
HUE068741T2 (hu) 2017-12-19 2025-01-28 Nanobiotix Nanorészecskék idegi zavarok kezelésére
ES2998117T3 (en) 2017-12-19 2025-02-19 Nanobiotix Nanoparticles for use in enhancing brain performances or in treating stress
WO2019157319A1 (en) * 2018-02-12 2019-08-15 Flagship Pioneering Innovations V, Inc. Devices and methods for delivering material into a biological tissue or cell
US12319711B2 (en) 2019-09-20 2025-06-03 Northwestern University Spherical nucleic acids with tailored and active protein coronae
US12378560B2 (en) 2019-10-29 2025-08-05 Northwestern University Sequence multiplicity within spherical nucleic acids
CN112546406B (zh) * 2020-11-20 2022-04-22 广东药科大学 一种微型机器人给药装置及给药系统
EP4568708A1 (en) * 2022-08-10 2025-06-18 Auburn University Shrinking nanomaterial for biomedical applications

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888176A (en) 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4933185A (en) 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
US5010167A (en) 1989-03-31 1991-04-23 Massachusetts Institute Of Technology Poly(amide-and imide-co-anhydride) for biological application
US6099864A (en) 1994-12-02 2000-08-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration In situ activation of microcapsules
US6107102A (en) 1995-06-07 2000-08-22 Regents Of The University Of California Therapeutic microdevices and methods of making and using same
US6395302B1 (en) * 1996-11-19 2002-05-28 Octoplus B.V. Method for the preparation of microspheres which contain colloidal systems
ES2130056B1 (es) * 1997-01-16 2000-02-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad oral de drogas de dificil absorcion.
CA2356705A1 (en) * 1998-11-20 2000-06-02 The General Hospital Corporation Permanent, removable tissue markings
US6355270B1 (en) * 1999-01-11 2002-03-12 The Regents Of The University Of California Particles for oral delivery of peptides and proteins
US20030114366A1 (en) * 1999-01-11 2003-06-19 Francis J. Martin Microfabricated particles and method for treating solid tumors
US6887493B2 (en) * 2000-10-25 2005-05-03 Adi Shefer Multi component controlled release system for oral care, food products, nutraceutical, and beverages
US6685927B2 (en) * 2001-09-27 2004-02-03 Ceramoptec Industries, Inc. Topical application of chromophores for hair removal
US7563451B2 (en) * 2003-07-22 2009-07-21 Iowa State University Research Foundation, Inc. Capped mesoporous silicates
CN101031287A (zh) * 2004-03-02 2007-09-05 麻省理工学院 纳米细胞药物递送系统
KR20090007275A (ko) 2005-12-20 2009-01-16 더 오하이오 스테이트 유니버시티 리서치 파운데이션 분석방법용 나노다공성 기판
WO2008054874A2 (en) * 2006-05-12 2008-05-08 Brown University Particles with high uniform loading of nanoparticles and methods of preparation thereof
US20100074958A1 (en) 2006-09-28 2010-03-25 Board Of Regents Of The University Of Texas System Methods and compositions for targeting fenestrated vasculature
US8563022B2 (en) * 2006-10-11 2013-10-22 Board Of Regents Of The University Of Texas System Particles for cell targeting
US8920625B2 (en) * 2007-04-27 2014-12-30 Board Of Regents Of The University Of Texas System Electrochemical method of making porous particles using a constant current density

Similar Documents

Publication Publication Date Title
JP2010500375A5 (enExample)
Cheng et al. A multifunctional nanoplatform against multidrug resistant cancer: merging the best of targeted chemo/gene/photothermal therapy
Batool et al. A detailed insight of the tumor targeting using nanocarrier drug delivery system
Maleki et al. The progress and prospect of zeolitic imidazolate frameworks in cancer therapy, antibacterial activity, and biomineralization
Pan et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles
Hasan et al. Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer
Zou et al. Virus‐mimicking chimaeric polymersomes boost targeted cancer siRNA therapy in vivo
Zeng et al. A drug‐self‐gated mesoporous antitumor nanoplatform based on pH‐sensitive dynamic covalent bond
Cattaneo et al. Nanotechnology and human health: risks and benefits
Fu et al. Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane
Davis The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic
ES2776126T3 (es) Nanopartículas de circulación prolongada para la liberación sostenida de agentes terapéuticos
Lindén Biodistribution and excretion of intravenously injected mesoporous silica nanoparticles: implications for drug delivery efficiency and safety
CN103655517B (zh) 一种胶质瘤归巢肽介导的靶向纳米递药系统及其制备方法
Liu et al. Harnessing the collective properties of nanoparticle ensembles for cancer theranostics
Zhang et al. Nanoparticle therapy for prostate cancer: overview and perspectives
Yang et al. Soft and condensed nanoparticles and nanoformulations for cancer drug delivery and repurpose
Ge et al. Human albumin fragments nanoparticles as PTX carrier for improved anti-cancer efficacy
Parmar et al. Factors affecting the clearance and biodistribution of polymeric nanoparticles
Yang et al. Recent advances of pH‐induced charge‐convertible polymer‐mediated inorganic nanoparticles for biomedical applications
Su et al. Biosynthetic and unfolded protein nanocarriers for chemotherapeutic drugs in oral cancers: improved bioavailability and safety of chemotherapeutics
Zhang et al. A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus
Thotakura et al. Assessing the pharmacokinetics and toxicology of polymeric micelle conjugated therapeutics
Martin-Palma et al. Nanostructured porous silicon-mediated drug delivery
Han et al. Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion Injury